Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadahiro Kitamura

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Plos One|March 3, 2012
FoxO1 gain of function in the pancreas causes glucose intolerance, polycystic pancreas, and islet hypervascularizationOsamu Kikuchi, Masaki Kobayashi, Kosuke Amano, et al.
Obesity (Silver Spring, Md.)|July 22, 2014
Sirt1 rescues the obesity induced by insulin-resistant constitutively-nuclear FoxO1 in POMC neurons of male miceVina Yanti Susanti, Tsutomu Sasaki, Hiromi Yokota-Hashimoto, et al.
Plos One|October 12, 2012
Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylationYukari Ido-Kitamura, Tsutomu Sasaki, Masaki Kobayashi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 7, 2021
Leucine induces cardioprotection in vitro by promoting mitochondrial function via mTOR and Opa-1 signalingAtsushi Morio, Rie Tsutsumi, Takashi Kondo, et al.
Diabetology & Metabolic Syndrome|November 21, 2021
Leucine imparts cardioprotective effects by enhancing mTOR activity and mitochondrial fusion in a myocardial ischemia/reperfusion injury murine modelAtsushi Morio, Rie Tsutsumi, Shiho Satomi, et al.
Molecular Metabolism|November 13, 2018
SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levelsTakayoshi Suga, Osamu Kikuchi, Masaki Kobayashi, et al.
Diabetes, Obesity & Metabolism|January 22, 2024
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective studyYuta Nakamura, Ichiro Horie, Tadahiro Kitamura, et al.
Endocrinology|June 27, 2012
Deficiency of proton-sensing ovarian cancer G protein-coupled receptor 1 attenuates glucose-stimulated insulin secretionTakashi Nakakura, Chihiro Mogi, Masayuki Tobo, et al.
Journal of Diabetes Investigation|November 18, 2024
Is glucose-induced hypersecretion of glicentin after the revision surgery using Roux-en-Y gastric bypass related to improved glycemic control due to insulin hypersecretion in a type 2 diabetes patient without diabetes remission after laparoscopic sleeve gastrectomy?Yukako Yamamoto, Osamu Sekine, Jun Ito-Kobayashi, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 26, 2025
Gut hormone secretion in a new meal tolerance test on insulin, glucagon, and glycemic excursions in patients with morbid obesity undergone sleeve gastrectomyYukako Yamamoto, Masaki Kobayashi, Takeshi Togawa, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Plos One|March 3, 2012
FoxO1 gain of function in the pancreas causes glucose intolerance, polycystic pancreas, and islet hypervascularizationOsamu Kikuchi, Masaki Kobayashi, Kosuke Amano, et al.
Obesity (Silver Spring, Md.)|July 22, 2014
Sirt1 rescues the obesity induced by insulin-resistant constitutively-nuclear FoxO1 in POMC neurons of male miceVina Yanti Susanti, Tsutomu Sasaki, Hiromi Yokota-Hashimoto, et al.
Plos One|October 12, 2012
Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylationYukari Ido-Kitamura, Tsutomu Sasaki, Masaki Kobayashi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 7, 2021
Leucine induces cardioprotection in vitro by promoting mitochondrial function via mTOR and Opa-1 signalingAtsushi Morio, Rie Tsutsumi, Takashi Kondo, et al.
Diabetology & Metabolic Syndrome|November 21, 2021
Leucine imparts cardioprotective effects by enhancing mTOR activity and mitochondrial fusion in a myocardial ischemia/reperfusion injury murine modelAtsushi Morio, Rie Tsutsumi, Shiho Satomi, et al.
Molecular Metabolism|November 13, 2018
SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levelsTakayoshi Suga, Osamu Kikuchi, Masaki Kobayashi, et al.
Diabetes, Obesity & Metabolism|January 22, 2024
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective studyYuta Nakamura, Ichiro Horie, Tadahiro Kitamura, et al.
Endocrinology|June 27, 2012
Deficiency of proton-sensing ovarian cancer G protein-coupled receptor 1 attenuates glucose-stimulated insulin secretionTakashi Nakakura, Chihiro Mogi, Masayuki Tobo, et al.
Journal of Diabetes Investigation|November 18, 2024
Is glucose-induced hypersecretion of glicentin after the revision surgery using Roux-en-Y gastric bypass related to improved glycemic control due to insulin hypersecretion in a type 2 diabetes patient without diabetes remission after laparoscopic sleeve gastrectomy?Yukako Yamamoto, Osamu Sekine, Jun Ito-Kobayashi, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 26, 2025
Gut hormone secretion in a new meal tolerance test on insulin, glucagon, and glycemic excursions in patients with morbid obesity undergone sleeve gastrectomyYukako Yamamoto, Masaki Kobayashi, Takeshi Togawa, et al.
Pageof 13